Literature DB >> 21402298

Brief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD).

Susan E Yount1, Seung W Choi, David Victorson, Bernice Ruo, David Cella, Susan Anton, Alan Hamilton.   

Abstract

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is a progressive disease with functional decline leading to disability. Dyspnea, the prominent symptom, can be measured using existing measures, but a lack of consensus about standardization of dyspnea measurement remains. We examined the psychometric performance of two item-response theory-based (IRT) measures of dyspnea and related functional limitations (FLs) in patients with COPD and simulated computerized adaptive testing (CAT) of the banks to determine the number of questions required to achieve high precision.
METHODS: A total of 102 patients completed banks measuring dyspnea and FLs (33 items), from which the 10-item dyspnea and FL short forms were scored as well as other self-report measures of respiratory and physical function and emotional distress. A subset of patients completed the banks 7 to 10 days later. Pulmonary function test results were obtained from medical charts.
RESULTS: The 33-item banks and 10-item short forms had excellent internal consistency (alphas >0.9) and test-retest reliability (intraclass correlation coefficients >0.89). Patients sorted by severity level on the Medical Research Council scale were differentiated by item banks (P < 0.001) and the short forms (P < 0.01). The banks and short forms were also associated with related measures of dyspnea (e.g., Baseline Dyspnea Index, r = 0.47-0.53), physical function (e.g., 36-Item Short Form Health Survey, r = -0.83 to -0.86) and forced expiratory volume in 1 second (r = -0.32 to -0.35). On average, CAT required 4 and 5 items for accurate measurement of dyspnea and FLs, respectively.
CONCLUSION: The Functional Assessment of Chronic Illness Therapy-Dyspnea short forms and banks provide options for brief, psychometrically sound measures of dyspnea and/or FLs in COPD.
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21402298     DOI: 10.1016/j.jval.2010.11.009

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  11 in total

1.  Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.

Authors:  Monique E Hinchcliff; Jennifer L Beaumont; Mary A Carns; Sofia Podlusky; Krishna Thavarajah; John Varga; David Cella; Rowland W Chang
Journal:  J Rheumatol       Date:  2014-11-01       Impact factor: 4.666

2.  Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Susan E Yount; Jennifer L Beaumont; Shih-Yin Chen; Karen Kaiser; Katy Wortman; David L Van Brunt; Jeffrey Swigris; David Cella
Journal:  Lung       Date:  2016-02-09       Impact factor: 2.584

3.  Therapeutic impact of red blood cell transfusion on anemic outpatients: the RETRO study.

Authors:  Elizabeth St Lezin; Matthew S Karafin; Roberta Bruhn; Dhuly Chowdhury; Lirong Qu; Walter Bialkowski; Scott Merenda; Pamela D'Andrea; Anne-Lyne McCalla; Lisa Anderson; Sheila M Keating; Mars Stone; Edward L Snyder; Donald Brambilla; Edward L Murphy; Philip J Norris; Joan F Hilton; Bryan R Spencer; Steven Kleinman; Jeffrey L Carson
Journal:  Transfusion       Date:  2019-03-18       Impact factor: 3.157

4.  Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease.

Authors:  Lucas M Donovan; Peter J Rise; Shannon S Carson; Laura C Feemster; Matthew F Griffith; Vishesh K Kapur; Jerry A Krishnan; Peter K Lindenauer; Richard A Mularski; Edward T Naureckas; Brian N Palen; Elizabeth C Parsons; Laura J Spece; Michael V Vitiello; David H Au
Journal:  Ann Am Thorac Soc       Date:  2017-12

5.  Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form.

Authors:  Monique Hinchcliff; Jennifer L Beaumont; Krishna Thavarajah; John Varga; Anh Chung; Sofia Podlusky; Mary Carns; Rowland W Chang; David Cella
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

6.  Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments.

Authors:  Kimberly Raymond; Susan Vallow; Cory Saucier; Kristi Jackson; Michelle K White; Andrew Lovley; Denise D'Alessio
Journal:  J Patient Rep Outcomes       Date:  2022-07-13

7.  Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease.

Authors:  Anne C Melzer; Laura C Feemster; Kristina Crothers; Shannon S Carson; Suzanne E Gillespie; Ashley G Henderson; Jerry A Krishnan; Peter K Lindenauer; Mary Ann McBurnie; Richard A Mularski; Edward T Naureckas; A Simon Pickard; David H Au
Journal:  Ann Am Thorac Soc       Date:  2016-09

Review 8.  Patient-reported outcome measures for chronic obstructive pulmonary disease : the exclusion of people with low literacy skills and learning disabilities.

Authors:  Deepa Jahagirdar; Thilo Kroll; Karen Ritchie; Sally Wyke
Journal:  Patient       Date:  2013       Impact factor: 3.883

9.  Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.

Authors:  David M Mannino; Emmanuelle M Clerisme-Beaty; Joanne Franceschina; Naitee Ting; Nancy K Leidy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-10

10.  Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form.

Authors:  Fang-Ju Lin; A Simon Pickard; Jerry A Krishnan; Min J Joo; David H Au; Shannon S Carson; Suzanne Gillespie; Ashley G Henderson; Peter K Lindenauer; Mary Ann McBurnie; Richard A Mularski; Edward T Naureckas; William M Vollmer; Todd A Lee
Journal:  BMC Med Res Methodol       Date:  2014-06-16       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.